Aplaviroc
Aplaviroc is a potent and selective CCR5 antagonist used to study HIV-1 infection mechanisms. It effectively inhibits viral strains including Ba-L, JRFL, and MOKW in vitro and has been investigated in clinical trials for antiviral therapy. This small molecule is a valuable research tool for exploring HIV entry inhibition and CCR5 receptor function.
Product Specifications
CAS Number
461443-59-4
Product Name Alternative
Aplaviroc, CCR5, AK602, AK-602, AK 602, ONO-4128, GSK 873140, GW873140, GW-873140, GW 873140, GSK873140, GSK-873140, HIV, HIV-1Ba-L, HIV-1JRFL, HIV-1MOKW, HIVProtease, HIV Protease
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
97.98% (May vary between batches)
Smiles
C (CCC) N1C2 (C (=O) N[C@] ([C@H] (O) C3CCCCC3) (C1=O) [H]) CCN (CC4=CC=C (OC5=CC=C (C (O) =O) C=C5) C=C4) CC2
Molecular Formula
C33H43N3O6
Molecular Weight
577.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1883461-01 0.01 mg
Human GPR27-Strep full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1883461-02 0.05 mg
Human GPR27-Strep full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1883461-03 0.1 mg
Human GPR27-Strep full length protein-synthetic nanodisc
Sign In for Pricing
View Details 
245291 50 µL
DEPC-1 (alkB, alkylation Repair Homolog 3 (E. coli), ABH3, DEPC-1, DEPC1, MGC118790, MGC118792, MGC118793, PCA1)
Sign In for Pricing
View Details 
MBS1167888-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Thymidine kinase (tdk)
Sign In for Pricing
View Details